We study a multiagent stochastic linear bandit with side information, parameterized by an unknown vector $\theta ^* \in \mathbb {R}^{d}$ . The information consists of finite collection low-dimensional subspaces, one which contains ^*$</...

Lymphoblastic lymphoma is a rare disease in adults, primarily affecting patients in their late teens and early 20s. Optimal treatment strategies have been slow to emerge because of the rarity of this disease and the variable distinction in the clinical literature between this condition and acute lymphoblastic leukemia. Although these two conditions are now regarded as a single entity in the WHO...

Extraordinary advances in the treatment outcome of childhood acute lymphoblastic leukemia (ALL) rank as one of the most successful stories in the history of oncology, with the current rate of approximately 80% of children being cured [1-5]. The improvements made have been mainly due to the development of intensive multiagent chemotherapy, identification of clinical and biologic variables predic...

T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive disease caused by the malignant transformation of immature progenitors primed towards T-cell development. Clinically, T-ALL patients present with diffuse infiltration of the bone marrow by immature T-cell blasts high blood cell counts, mediastinal involvement, and diffusion to the central nervous system. In the past decade, the genomi...

Evolution of multiagent chemotherapy and independent risk factors have improved survival rates approximately 80% in children with acute lymphoblastic leukemia. Although, 20-30% of patients will be relapsed within the treatment process1. Outcome assessment based on risk factors could remarkably help to prevent relapse at this malignancy2. Hence, ALL patients based on risk factors such as age, wh...